An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems

Jacob Lavee*, Johanna Mulzer, Thomas Krabatsch, Silvana Marasco, David McGiffin, Jens Garbade, Jan D. Schmitto, Daniel Zimpfer, Evgenij V. Potapov

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Abstract

Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.

Original languageEnglish
Pages (from-to)1399-1402
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume37
Issue number12
DOIs
StatePublished - Dec 2018

Keywords

  • bi-ventricular assist device
  • bi-ventricular failure
  • continuous flow ventricular assist device
  • left ventricular assist device
  • right ventricular assist device
  • total artificial heart

Fingerprint

Dive into the research topics of 'An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems'. Together they form a unique fingerprint.

Cite this